Skip to content
HeyJared

Jackie Fortiér

Reporter · US

Indexed articles, last 90 days
67
Latest publication
Aug 30, 2026
Outlet visibility, for Nhpr
Top 500K sites
Earliest in this view
Aug 19, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 30, 2026 · By Jackie Fortiér (NPR)

    Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify | WNYC (opens the original)

    Excerpt · English

    Read excerpt

    In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn't afford the $750 monthly price tag. Then Medicare launched an 18-month pilot program that offers GLP-1 medications to some enrollees for only $50 a month. La Marca thought he might finally be able to afford the drug. "I thought, 'Thank God, there's a path,'" said La Marca, who lives in Basking Ridge, N.J., and has tried numerous diets and exercise regimes. But the 68-year-old's celebration was

  2. Article · Aug 30, 2026 · Jackie Fortiér

    Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify (opens the original)

    Excerpt · English

    Read excerpt

    In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn't afford the $750 monthly price tag. Then Medicare launched an 18-month pilot program that offers GLP-1 medications to some enrollees for only $50 a month. La Marca thought he might finally be able to afford the drug. "I thought, 'Thank God, there's a path,'" said La Marca, who lives in Basking Ridge, N.J., and has tried numerous diets and exercise regimes. But the 68-year-old's celebration was

  3. Article · Aug 30, 2026 · Jackie Fortiér

    Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify (opens the original)

    Excerpt · English

    Read excerpt

    In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn't afford the $750 monthly price tag. Then Medicare launched an 18-month pilot program that offers GLP-1 medications to some enrollees for only $50 a month. La Marca thought he might finally be able to afford the drug. "I thought, 'Thank God, there's a path,'" said La Marca, who lives in Basking Ridge, N.J., and has tried numerous diets and exercise regimes. But the 68-year-old's celebration was

  4. Article · Aug 30, 2026 · Jackie Fortiér

    Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify (opens the original)

    Excerpt · English

    Read excerpt

    In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn't afford the $750 monthly price tag. Then Medicare launched an 18-month pilot program that offers GLP-1 medications to some enrollees for only $50 a month. La Marca thought he might finally be able to afford the drug. "I thought, 'Thank God, there's a path,'" said La Marca, who lives in Basking Ridge, N.J., and has tried numerous diets and exercise regimes. But the 68-year-old's celebration was

  5. Article · Aug 30, 2026 · Jackie Fortiér

    Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify (opens the original)

    Excerpt · English

    Read excerpt

    In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn't afford the $750 monthly price tag. Then Medicare launched an 18-month pilot program that offers GLP-1 medications to some enrollees for only $50 a month. La Marca thought he might finally be able to afford the drug. "I thought, 'Thank God, there's a path,'" said La Marca, who lives in Basking Ridge, N.J., and has tried numerous diets and exercise regimes. But the 68-year-old's celebration was

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 500K sites

For Nhpr, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

How this was measured

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Jackie Fortiér